Ovo bi moglo biti pojačano time što bi u maju grčku farmaceutsku kompaniju Specifar za 400 miliona eura mogla otkupiti firma Watson Pharmaceuticals iz Kalifornije, koja ima sjedište u New Jerseyju.
They could be boosted though by the acquisition in May of the Greek pharmaceutical company Specifar for 400m euros by Watson Pharmaceuticals of California, which has its headquarters in New Jersey.